KRYS EBITDA Growth
Krystal Biotech Inc · EBITDA Growth
KRYS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported22.10%period ending
KRYS TTM EBITDA YoY % (-293.10% → 22.10%)
Year-over-year change
High-resolution chart · PNG
KRYS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 22.1001% | |
| 29.5092% | |
| 55.995% | |
| 144.2442% | |
| 44.3857% | |
| 121.4481% | |
| 325.4649% | |
| 607.4575% | |
| 198.5827% | |
| 157.3601% | |
| 120.256% | |
| 87.621% | |
| -13.1105% | |
| -21.4053% | |
| -108.1183% | |
| -132.3607% | |
| -130.5331% | |
| -156.2615% | |
| -115.1649% | |
| -105.9369% | |
| -117.2477% | |
| -80.6904% | |
| -42.2886% | |
| -33.4634% | |
| -27.3437% | |
| -51.9431% | |
| -77.8259% | |
| -114.2733% | |
| -110.8508% | |
| -116.8717% | |
| -151.3831% | |
| -137.0847% | |
| -293.1034% |